UTS site search
Centre for Health Economics Research and Evaluation
Project spotlight
CREST logo


CREST is the health economics national technical service established at CHERE and funded by Cancer Australia to develop resources to assist the Cancer Collaborative Clinical Trials Groups in the incorporation of health and pharmaco-economic analyses into trial protocols, as well as to build capacity for health economics.
Health Technology Assessment

Health Technology Assessment

The Economic Evaluation team at CHERE has expertise in undertaking economic evaluations of new health technologies and programs. It undertakes commissioned research for a range of agency, and also conducts rigorous evaluations of submissions and applications being considered by the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC).
Research looking at what matters to women when they make decisions about breast cancer should lead to better informed choices
This report presents results from a series of surveys and discrete choice experiments (DCEs) for a policy-relevant case study of advertising of a pharmacist only product, using a realistic hypothetical information style advertisement.
Research Action awards were established in 2015 to recognise researchers whose work has made a real-world difference to health policy and practice, and to people’s health and wellbeing.
CHERE celebrates 25 years of achievement and impact in health economics. Listen to Professor Tom Buchmueller presenting "Obamacare and the way ahead"